A detailed history of Jones Financial Companies Lllp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Jones Financial Companies Lllp holds 105 shares of BMRN stock, worth $6,996. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105
Previous 85 23.53%
Holding current value
$6,996
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$69.02 - $93.84 $1,380 - $1,876
20 Added 23.53%
105 $7,000
Q2 2024

Aug 14, 2024

BUY
$74.43 - $92.22 $6,326 - $7,838
85 New
85 $6,000
Q4 2023

Feb 13, 2024

BUY
$76.22 - $98.51 $34,299 - $44,329
450 New
450 $43,000
Q2 2021

Aug 12, 2021

SELL
$75.51 - $84.79 $1,283 - $1,441
-17 Closed
0 $0
Q1 2021

Apr 30, 2021

SELL
$74.73 - $90.69 $5,231 - $6,348
-70 Reduced 80.46%
17 $1,000
Q4 2020

Feb 08, 2021

BUY
$72.61 - $90.2 $6,317 - $7,847
87 New
87 $8,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.